Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/2010
10/21/2010US20100267136 Fabrication of vascularized tissue using microfabricated two-dimensional molds
10/21/2010US20100267135 Multipotent/pluripotent cells and methods
10/21/2010US20100267134 Isolation, characterization and differentiation of in vitro adult human germ line stem cells
10/21/2010US20100267133 Acrtiib-fc polynucleotides, polypeptides, and compositions
10/21/2010US20100267132 In vitro preservation of living animal cells and compounds suitable for use in the preservation of living animal cells
10/21/2010US20100267131 Feline Pancreatic Lipase
10/21/2010US20100267130 Chlamydomonas Intraflagellar Transport 88 (IFT-88)
10/21/2010US20100267129 Chimeric nucleic acids encoding polypeptides comprising domains of tnf family ligands
10/21/2010US20100267128 Compositions and method for use in isolation of nucleic acid molecules
10/21/2010US20100267118 Recombinational cloning using nucleic acids having recombination sites
10/21/2010US20100267116 Filovirus vectors and noninfectious filovirus-based particles
10/21/2010US20100267115 Production of 3-hydroxypropionic acid using beta-alanine/pyruvate aminotransferase
10/21/2010US20100267114 Glucoamylase Variants with Altered Properties
10/21/2010US20100267112 Use of pks 13 protein coding for condensase of mycolic acids of mycobacteria and related strains as an antibiotics target
10/21/2010US20100267107 Methods for isolating very small embryonic-like (vsel) stem cells
10/21/2010US20100267087 MUTANT PYRROLYSYL-tRNA SYNTHETASE, AND METHOD FOR PRODUCTION OF PROTEIN HAVING NON-NATURAL AMINO ACID INTEGRATED THEREIN BY USING THE SAME
10/21/2010US20100267084 Protein glycosylation modification in methylotrophic yeast
10/21/2010US20100267079 Identification and isolation of transitional cell carcinoma stem cells
10/21/2010US20100267075 Microfluidic lysis
10/21/2010US20100267073 Stem cell-based culture system for drug development
10/21/2010US20100267072 Formation/Elongation of Axon by Inhibiting the Expression or Function of Singar and Application to Nerve Regeneration
10/21/2010US20100267070 Pharmaceutical compositions for the treament of conditions responsive to proteasome inhibition
10/21/2010US20100267047 Test Method on Feline Vaccinated with Feline Immunodeficiency Virus Vaccine, and Antigen for Use in the Test
10/21/2010US20100267027 Her-2 binding antagonists
10/21/2010US20100267024 Mutations in the macrophage scavenger receptor 1 gene alter risk of prostate cancer, asthma, and cardiovascular disease
10/21/2010US20100267022 Monocyte-derived nucleic acids and related compositions and methods
10/21/2010US20100267002 Peptide having life-lengthening effect on cells
10/21/2010US20100266698 Use of insulin for the treatment of cartilaginous disorders
10/21/2010US20100266686 Anti-amyloid antibodies and their use in diagnosis and therapy of amyloid diseases
10/21/2010US20100266673 Compositions and methods for the delivery of nitric oxide
10/21/2010US20100266642 Modified cells for targeted cell trafficking and uses thereof
10/21/2010US20100266639 Expression system
10/21/2010US20100266631 Compositions and Methods for Generating an Immune Response Utilizing Alphavirus-Based Vector Systems
10/21/2010US20100266630 Recombinant MVA virus, and the use thereof
10/21/2010US20100266617 Antibodies to human programmed death receptor pd-1
10/21/2010US20100266616 Polypeptides, antibody variable domains and antagonists
10/21/2010US20100266613 Anti-tnf-alpha antibodies and their uses
10/21/2010US20100266612 Bmp-alk3 antagonists and uses for promoting bone growth
10/21/2010US20100266609 Antibody Molecules Which Bind IL-17A and IL-17F
10/21/2010US20100266606 Antibody therapy for highly pathogenic avian influenza virus
10/21/2010US20100266601 Antibodies that inhibit tslp activity
10/21/2010US20100266598 Peptide that elicits neutralizing antibodies targeting the hiv co-receptor, ccr5
10/21/2010US20100266593 Wnt antagonists and their use in the diagnosis and treatment of wnt-mediated disorders
10/21/2010US20100266592 Therapeutic antennapedia-antibody molecules and methods of use thereof
10/21/2010US20100266585 Monoclonal Antibodies Specific to Hemagglutinin and Neuraminidase from Influenza Virus H5-Subtype or N1-Subtype and Uses Thereof
10/21/2010US20100266575 SOLUBLE FMS-LIKE TYROSINE KINASE-1 (sFLT-1) ANTIBODY AND RELATED COMPOSITION, KIT, METHODS OF USING, AND MATERIALS AND METHOD FOR MAKING
10/21/2010US20100266569 Prostatic acid phosphatase for the treatment of pain
10/21/2010US20100266564 Polyunsaturated Fatty Acid Synthase Nucleic Acid Molecules and Polypeptides, Compositions, and Methods of Making and Uses Thereof
10/21/2010US20100266563 Selective cytopheresis devices and related methods thereof
10/21/2010US20100266561 Recovery of Tissue Function Following Administration of B Cells to Injured Tissue
10/21/2010US20100266556 Method for expanding hematopoietic stem cells using heterocyclic compound
10/21/2010US20100266553 Method for isolating and culturing adult stem cells derived from human amniotic epithelium
10/21/2010US20100266548 LPS-Responsive CHS1/Beige-Like Anchor Gene and Therapeutic Applications Thereof
10/21/2010US20100266546 Selectively replicating viral vectors
10/21/2010US20100266541 Methods and agents for modulating an immune response
10/21/2010US20100266531 Il-17 binding proteins
10/21/2010US20100266530 FcRN ANTIBODIES AND USES THEREOF
10/21/2010US20100266507 Luminescent compounds
10/21/2010US20100266502 Pharmaceutical composition comprising anti-HB-EGF antibody as active ingredient
10/21/2010US20100266498 Nucleic acid and corresponding protein entitled 125p5c8 useful in treatment and detection of cancer
10/21/2010US20100266497 Internalizing Anti-CD74 Antibodies and Methods of Use
10/21/2010US20100266493 Agonist antibodies against tshr
10/21/2010US20100266492 Compounds for intracellular delivery of therapeutic moieties to nerve cells
10/21/2010CA2758120A1 Engineered mesenchymal stem cells and method of using same to treat tumors
10/21/2010CA2758003A1 Methods and compositions for stem cell cultures
10/21/2010CA2757382A1 Anti-fcrh5 antibodies and immunoconjugates and methods of use
10/21/2010CA2686141A1 Method for cellular tissue multiplication from jatropha curcas
10/20/2010EP2241623A2 Monoclonal antibody against a human cytokine receptor
10/20/2010EP2241622A2 Human trk receptors and their derivatives
10/20/2010EP2241618A1 Prostate cancer cell lines and their use in screening method
10/20/2010EP2241617A1 Multipotent cells derived from blood and methods and uses related thereto
10/20/2010EP2241577A1 Anti-CD37 antibodies
10/20/2010EP2241330A1 Contraceptive methods and compositions related to proteasomal interference
10/20/2010EP2241329A2 Anti-interleukin-9 antibody or anti-interleukin-9 receptor antibody for treating bronchial hyper-responsiveness
10/20/2010EP2241295A1 Methods and devices for selective disruption of fatty tissue by controlled cooling
10/20/2010EP2240572A2 Use of rna for reprogramming somatic cells
10/20/2010EP2240536A1 Synthetic surfaces for culturing stem cell derived oligodendrocyte progenitor cells
10/20/2010EP1866415B1 A cysteine-containing peptide tag for site-specific conjugation of proteins
10/20/2010EP1835949B1 Tissue engineering devices for the repair and regeneration of tissue
10/20/2010EP1412484B1 Use of lysyl oxidase inhibitors for cell culture and tissue engineering
10/20/2010EP1373502B1 Dopaminergic neuronal survival-promoting factors and uses thereof
10/20/2010EP1366366B1 Compositions and methods for the diagnosis, treatment and prevention of steroid hormone responsive cancers
10/20/2010EP1282693B1 Human coagulation factor vii variants
10/20/2010EP1060241B2 Preparation of cells for production of biologicals
10/20/2010EP0710280B1 Method for production of high titer virus and high efficiency retroviral mediated transduction of mammalian cells
10/20/2010CN1509327B CD4+CD25+regulatory T cells from human blood
10/20/2010CN101868540A Vaccine for swine edema disease
10/20/2010CN101868536A Optimised and defined method for isolation and preservation of precursor cells from human umbilical cord
10/20/2010CN101868535A Kidney-derived stem cell population, identification and therapeutic use
10/20/2010CN101868534A A method for identifying, expanding, and removing adult stem cells and cancer stem cells
10/20/2010CN101868533A Paracrine signals from mesenchymal feeder cells and regulating expansion and differentiation of hepatic progenitors using same
10/20/2010CN101864463A Method for biologically synthesizing conjugated linoleic acid CLA
10/20/2010CN101864451A Hoofed mammal inducible multipotential stem cell and preparation method thereof
10/20/2010CN101864437A Glyphosate-resistant 5-enolpyruvyl-shikimate-3-phosphate synthase gene and application thereof
10/20/2010CN101864435A Turbot reovirus whole genome and application thereof
10/20/2010CN101864432A S. agalactiae antigens I + II
10/20/2010CN101864431A S. agalactiae antigens I + II
10/20/2010CN101864429A Method for cultivating cotton bollworm resistant plant by corn Lc gene
10/20/2010CN101864422A Satellite composition type expression promoter of malvastrum yellow vein viruses
10/20/2010CN101864419A Mouse Miwi promoter as well as carrier and application thereof
1 ... 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 ... 1827